The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer
- Conditions
- Prostate AdenocarcinomaObesity, Morbid
- Interventions
- Locations
- 🇺🇸
Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma
- Conditions
- Unresectable Intrahepatic Cholangiocarcinoma
- Interventions
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2025-02-11
- Target Recruit Count
- 5
- Registration Number
- NCT04301778
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression
- Conditions
- Prostatic Neoplasm
- Interventions
- Behavioral: EMPOWER
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2025-02-12
- Target Recruit Count
- 20
- Registration Number
- NCT04266431
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
- Conditions
- Fibrolamellar Hepatocellular Carcinoma (FLC)
- Interventions
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2024-06-07
- Target Recruit Count
- 56
- Registration Number
- NCT04248569
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2025-02-27
- Target Recruit Count
- 50
- Registration Number
- NCT04243473
- Locations
- 🇺🇸
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide
- Conditions
- Primary Immune Deficiency DisorderImmune Deficiency DiseaseBone Marrow Failure
- Interventions
- Radiation: Low Dose Total Body Irradiation
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2024-12-06
- Target Recruit Count
- 27
- Registration Number
- NCT04232085
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma
- Conditions
- Advanced Gastric Adenocarcinoma
- Interventions
- First Posted Date
- 2019-12-24
- Last Posted Date
- 2024-05-31
- Target Recruit Count
- 36
- Registration Number
- NCT04209686
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Resiliency in Older Adults Undergoing Bone Marrow Transplant
- Conditions
- Myelodysplastic SyndromeLymphomaNon-Hodgkins LymphomaLeukemiaAcute Myelogenous LeukemiaBlood Cancer
- Interventions
- Other: Bone Marrow Transplant (BMT)
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2025-04-01
- Target Recruit Count
- 126
- Registration Number
- NCT04188678
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2024-02-23
- Target Recruit Count
- 25
- Registration Number
- NCT04177810
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy
- Conditions
- Pancreaticoduodenectomy
- Interventions
- Procedure: robotic pancreaticoduodenectomy
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2025-01-06
- Target Recruit Count
- 81
- Registration Number
- NCT04171440
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸Atrium Health, Charlotte, North Carolina, United States